Email This Article
Headlines & Perspectives
Biotech Watch: Elan's Alzheimer's Drug Data
By
Adam Feuerstein
06/13/08 - 12:41 PM EDT
The potential market for bapineuzumab is massive. Here's how to sort the trial data when released.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,471.50 | 1,106.41 | 2,190.31 | 35.40 |
Oil *
71.66
|
|
UP
65.67
|
UP
4.06
|
DOWN
0.55
|
UP
0.58
|
10 Yr
3.54%
SPDR Gold
109.32
|
|
+0.63%
|
+0.37%
|
-0.03%
|
+1.67%
|
Data delayed 20 minutes |


Connect with TheStreet